West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
West Pharmaceutical Services has declared a third-quarter 2021 dividend of $0.17 per share, scheduled for payment on August 4, 2021, to shareholders recorded as of July 21, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
West Pharmaceutical Services has declared a third-quarter 2021 dividend of $0.17 per share, scheduled for payment on August 4, 2021, to shareholders recorded as of July 21, 2021. This dividend reflects the company's ongoing commitment to return value to its shareholders. Additionally, management will present a business overview at the Bank of America Securities 2021 Healthcare Conference on May 11, 2021, at 2:45 p.m. EDT. West generated over $2.15 billion in sales in fiscal year 2020.
Positive
- Declared a dividend of $0.17 per share, enhancing shareholder returns.
- Participation in the Bank of America Securities 2021 Healthcare Conference indicates active investor engagement.
Negative
- None.
Details
News Market Reaction – WST
The recorded move for WST in the trading session of this news was -0.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EXTON, Pa., May 5, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2021 dividend of
The Company also announced that management will present an overview of the business for investors at the upcoming Bank of America Securities 2021 Healthcare Conference taking place virtually on Tuesday, May 11, 2021 at 2:45 p.m. EDT.
A live audio webcast of the presentation and a copy of the presentation materials will be accessible from the Company's website at www.westpharma.com/en/investors.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:http://www.prnewswire.com/news-releases/west-announces-third-quarter-dividend-and-participation-in-upcoming-investor-conference-301283940.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.